OnBoard Cleveland (OBC) guides early-career professionals to analyze and employ individual strengths to maximize contributions in both professional and civic settings.
OnBoard Cleveland will challenge you to develop skills for confident networking, presentations and professional interactions. Through OnBoard, you’ll:
- Analyze and employ your individual strengths to maximize contributions in professional settings and community involvements.
- Gain an appreciation of the local assets, better understand critical community issues and learn collaborative leadership skills to address them.
- Get connected to civic opportunities that align with your personal interests and talents.
- Your Commitment
Participants are expected to attend a one and a half-day opening retreat, with a mandatory overnight stay, and six, three and a half-hour evening sessions (5:30 – 9:00 p.m.) once per month from September through March.
Tuition for the class of 2022 is $2,250 per participant (typically paid by the employer). Tuition includes food, materials, session activities and the overnight stay.
Partial scholarships are available, and CLC will work with successful applicants to ensure tuition is not a barrier. Scholarships are determined via the scholarship application form that will be available on the same dates as the program application.
- Application process
Participants are chosen through a blind selection process. A volunteer alumni panel reviews all submissions and scores applicants on their commitment to building a civic/professional network, and willingness to expand self-awareness of personal and professional strengths and challenges.
The program application form includes three short answer questions, a brief overview of your community involvement and one recommendation (which must be completed on the online application – no letters will be accepted).
Applications are open February 1-28. There is a non-refundable $25 application fee.
Cleveland Leadership Center adheres to the CLEan Committed practices to minimize the spread of COVID-19. Learn more >